142 related articles for article (PubMed ID: 10995777)
21. A short proximal promoter and the distal hepatic control region-1 (HCR-1) contribute to the liver specificity of the human apolipoprotein C-II gene. Hepatic enhancement by HCR-1 requires two proximal hormone response elements which have different binding specificities for orphan receptors HNF-4, ARP-1, and EAR-2.
Vorgia P; Zannis VI; Kardassis D
J Biol Chem; 1998 Feb; 273(7):4188-96. PubMed ID: 9461615
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors.
Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P
J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428
[TBL] [Abstract][Full Text] [Related]
23. Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor beta1 stimulation of alpha 2(I)-collagen (COL1A2) transcription.
Zhang W; Ou J; Inagaki Y; Greenwel P; Ramirez F
J Biol Chem; 2000 Dec; 275(50):39237-45. PubMed ID: 11007770
[TBL] [Abstract][Full Text] [Related]
24. DNA binding and transcription activation specificity of hepatocyte nuclear factor 4.
Fraser JD; Martinez V; Straney R; Briggs MR
Nucleic Acids Res; 1998 Jun; 26(11):2702-7. PubMed ID: 9592157
[TBL] [Abstract][Full Text] [Related]
25. Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoids.
Kardassis D; Roussou A; Papakosta P; Boulias K; Talianidis I; Zannis VI
Biochem J; 2003 Jun; 372(Pt 2):291-304. PubMed ID: 12585964
[TBL] [Abstract][Full Text] [Related]
26. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
27. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
[TBL] [Abstract][Full Text] [Related]
28. Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene.
Ribeiro A; Pastier D; Kardassis D; Chambaz J; Cardot P
J Biol Chem; 1999 Jan; 274(3):1216-25. PubMed ID: 9880489
[TBL] [Abstract][Full Text] [Related]
29. SREBP-1 binds to multiple sites and transactivates the human ApoA-II promoter in vitro : SREBP-1 mutants defective in DNA binding or transcriptional activation repress ApoA-II promoter activity.
Pissios P; Kan HY; Nagaoka S; Zannis VI
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1456-69. PubMed ID: 10364076
[TBL] [Abstract][Full Text] [Related]
30. FLRG, an activin-binding protein, is a new target of TGFbeta transcription activation through Smad proteins.
Bartholin L; Maguer-Satta V; Hayette S; Martel S; Gadoux M; Bertrand S; Corbo L; Lamadon C; Morera AM; Magaud JP; Rimokh R
Oncogene; 2001 Sep; 20(39):5409-19. PubMed ID: 11571638
[TBL] [Abstract][Full Text] [Related]
31. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.
Ghosh AK; Yuan W; Mori Y; Varga J
Oncogene; 2000 Jul; 19(31):3546-55. PubMed ID: 10918613
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional regulation of the human apolipoprotein genes.
Zannis VI; Kan HY; Kritis A; Zanni E; Kardassis D
Front Biosci; 2001 Mar; 6():D456-504. PubMed ID: 11229886
[TBL] [Abstract][Full Text] [Related]
33. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
34. Two initiator-like elements are required for the combined activation of the human apolipoprotein C-III promoter by upstream stimulatory factor and hepatic nuclear factor-4.
Pastier D; Lacorte JM; Chambaz J; Cardot P; Ribeiro A
J Biol Chem; 2002 Apr; 277(17):15199-206. PubMed ID: 11839757
[TBL] [Abstract][Full Text] [Related]
35. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
36. Both Max and TFE3 cooperate with Smad proteins to bind the plasminogen activator inhibitor-1 promoter, but they have opposite effects on transcriptional activity.
Grinberg AV; Kerppola T
J Biol Chem; 2003 Mar; 278(13):11227-36. PubMed ID: 12551947
[TBL] [Abstract][Full Text] [Related]
37. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
Zhang Y; Feng XH; Derynck R
Nature; 1998 Aug; 394(6696):909-13. PubMed ID: 9732876
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism.
Lindemann RK; Ballschmieter P; Nordheim A; Dittmer J
J Biol Chem; 2001 Dec; 276(49):46661-70. PubMed ID: 11590145
[TBL] [Abstract][Full Text] [Related]
39. Contribution of the hormone-response elements of the proximal ApoA-I promoter, ApoCIII enhancer, and C/EBP binding site of the proximal ApoA-I promoter to the hepatic and intestinal expression of the ApoA-I and ApoCIII genes in transgenic mice.
Kan HY; Georgopoulos S; Zanni M; Shkodrani A; Tzatsos A; Xie HX; Zannis VI
Biochemistry; 2004 May; 43(17):5084-93. PubMed ID: 15109267
[TBL] [Abstract][Full Text] [Related]
40. Induction of platelet-derived growth factor B-chain expression by transforming growth factor-beta involves transactivation by Smads.
Taylor LM; Khachigian LM
J Biol Chem; 2000 Jun; 275(22):16709-16. PubMed ID: 10828062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
